Asia Pacific Continuous Glucose Monitoring Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

The International Diabetes Federation (IDF) estimated that 80% of individuals with diabetes live in low- and middle-income countries, and of the total, more than 60% live in Asia, with almost one-third in China. The study of Asia Pacific Continuous Glucose Monitoring Market was undertaken by Astute Analytica, and the market is expected to witness a major rise in its revenue from US$ 1,081.6 Mn in 2021 to US$ 2,967.2 Mn by the end of 2030. The market is registering a CAGR of 12.22% over the forecast period. 

Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night on a continual basis by insulin-requiring people with diabetes, for instance, people with type I, type II diabetes or other types of diabetes. The user can see his glucose level anytime at a glance. CGM systems helps in better management of glucose levels every day, have fewer low blood glucose emergencies, and need fewer finger sticks. A continuous glucose monitor consists of three parts: a small electrode placed under the skin, a transmitter sending readings at regular intervals (ranging from every 5 to 15 min), and a separate receiver.

The market is majorly driven by factors such as increased awareness among people towards monitoring and preventive health and surge in diabetic population. Rising disposable income in Asia Pacific countries followed by the growing awareness about the advantages of good healthcare systems and healthier lifestyles is accelerating market growth. Further, the increasing prevalence of diabetes in Asia is another factor propelling the market growth. In 2019, the International Diabetes Federation (IDF) estimated that 463 million people had diabetes worldwide, and by 2045, this was predicted to rise to 700 million. Eighty percent of these live in low- and middle-income countries, and of the total, more than 60% live in Asia, with almost one-third in China. Major increases in the prevalence of diabetes have occurred in developing countries due to rapid and ongoing socioeconomic transition and will likely lead to further rises. The prevalence of both type 1 and type 2 diabetes (T2DM) has increased significantly during recent decades. The increasing prevalence of diabetes can be attributed to a multitude of interrelated factors, including rapid urbanization, sedentary lifestyles, unhealthy diets, tobacco use, and increasing life expectancy. Further, diabetes is a growing challenge in India with estimated 8.7% diabetic population in the age group of 20 and 70 years. However, CGM devices can be expensive, and the results might not be accurate as a fingerstick check. 

Key Insights of the Report: 

• Latest study published by Astute Analytica analyzes the Asia Pacific Continuous Glucose Monitoring Market for the study period of 2017-2030; where historical years are 2017-2020, base year is 2021 and forecast period is 2022-2030.
• The research report offers detailed study of market determinants including market drivers, restraints, opportunities, and trends; along with attractive presentation in the form of impact analysis to gain a simpler and easy comparison view of all market determinants.
• The research study is a compilation of 17 chapters distributed across 182 pages with 35 list of tables and 118 list of figures.
• The market is segmented based on component, demographics, end users, and country.
• The market estimates are presented in terms of value (US$ Mn).
• Along with market estimations, the market study was conducted on the basis of various economic models such as PESTLE and Porter’s five force models.
• A detailed value chain analysis of the industry was conducted. It includes developers, technology integrators, service providers, and end-users.
• The competitive dashboard section includes analysis on the basis of Concentration Ratio (CR), based on market size and market presence of key companies.

Key Takeaways from the Asia Pacific Continuous Glucose Monitoring Market Report:

• Based on component, the sensors segment holds the highest market share in 2021 and registers the highest CAGR over the forecast period 2022-2030. CGM works through a tiny sensor inserted under skin. The sensor measures interstitial glucose level, which is the glucose found in the fluid between the cells. The sensor tests glucose every few minutes. The segmental growth of sensors is thus attributed to advantages such as detailed glucose level data, user friendly, and best in budget.
• In terms of demographics, the adult population holds the highest share in the Asia Pacific CGM market in 2021 and are expected to continue their dominance over the forecast period. Adults aged 45 to 64 years are most prone to diabetes and need CGM on regular basis which makes adult population segment to hold highest market share.
• Based on end-users, home health care has the highest market share in 2021 and further registers the highest annual growth rate over the projection period. This is because CGM provides dynamic information, gives patient timely check on nutrition, activity, and insulin requirements, which can be easily tracked and managed at home, thereby reducing the hospital cost.
• China is the highest shareholder country in the Asia Pacific continuous glucose monitoring market in 2021 as one third of the diabetic patients of Asia Pacific are in China. Further, India records the highest CAGR over the projection period. This is because in India, diabetes is the fastest growing health condition, and the country has a significant population with high diabetes condition.

Competitive Landscape

Many companies are operating in the Asia Pacific Continuous Glucose Monitoring (CGM) Market to provide various products. The key market players are Medtronic Plc, Abbott Lab, DexCom Inc., Senseonics Holding Inc., F. Hoffmann-La Roche Ltd., and Johnson & Johnson among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.

Segmentation Overview

The following are the different segments of the Asia Pacific Continuous Glucose Monitoring (CGM) Market:

By Component segment of the Asia Pacific Continuous Glucose Monitoring (CGM) Market is sub-segmented into:

• Sensors
• Transmitters & Receivers
• Integrated Insulin Pumps
• Others

By Demographics segment of the Asia Pacific Continuous Glucose Monitoring (CGM) Market is sub-segmented into:

• Child Population (<14 years)
• Adult Population (>14 years)

By End user segment of the Asia Pacific Continuous Glucose Monitoring (CGM) Market is sub-segmented into:

• Diagnostics/Clinics
• ICUs
• Home Healthcare

By Country segment of the Asia Pacific Continuous Glucose Monitoring (CGM) Market is sub-segmented into:

• China
• India
• Japan
• South Korea
• Australia & New Zealand
• Indonesia
• ASEAN
  • Malaysia
  • Thailand
  • Philippines
  • Vietnam
  • Singapore
• Rest of Asia Pacific